Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ah 23848

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ah 23848 in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(ah 23848)
Trials
(ah 23848)
Recent Studies (post-2010) (ah 23848)
9,15618755289312

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wise, H1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ah 23848

ArticleYear
Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation.
    Prostaglandins, leukotrienes, and essential fatty acids, 1998, Volume: 58, Issue:1

    Topics: Animals; Biphenyl Compounds; Cell Aggregation; Cyclic AMP; Dinoprostone; Epoprostenol; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Rolipram

1998